Cumbo Alexander G.'s Insider Trades & SAST Disclosures
Cumbo Alexander G.'s most recent trade in Solid Biosciences Inc was a trade of 30,031 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cumbo Alexander G..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 90,094 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 30,031 | 72,082 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.96 per share. | 13 Feb 2025 | 11,365 | 60,717 (0%) | 0% | 4.0 | 45,005 | Common Stock |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 401,600 | 401,600 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 57,225 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 28,612 | 49,598 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | G. Cumbo Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 02 Dec 2024 | 11,114 | 38,484 (0%) | 0% | 5.6 | 62,236 | Common Stock |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 136,139 | 136,139 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | G. Alexander Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 240,250 | 240,250 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 120,125 | 120,125 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Cumbo Alexander G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 85,837 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander Cumbo G. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 28,612 | 29,196 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Cumbo G. Alexander | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.77 per share. | 02 Dec 2023 | 11,757 | 17,439 (0%) | 0% | 2.8 | 32,516 | Common Stock |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,642 | 26,642 | - | - | Stock Option (right to buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 228,900 | 228,900 | - | - | Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 114,449 | 114,449 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Alexander G. Cumbo | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 584 | 584 (0%) | 0% | - | Common Stock | |
| Verve Therapeutics Inc | Alexander G. Cumbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 31,000 | 31,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges